Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHFSNASDAQ:CTSONASDAQ:MODDNASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$4.79$4.86▼$37.50$5.80M1.55467,323 shs89,699 shsCTSOCytosorbents$0.97-2.0%$1.07$0.70▼$1.61$60.63M1.17144,070 shs151,955 shsMODDModular Medical$0.88-9.6%$1.05$0.68▼$2.65$35.79M0.33202,968 shs688,385 shsSTRRStar Equity$2.19-3.5%$2.24$2.05▼$5.35$7.05M0.6712,955 shs13,274 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis0.00%-1.56%-23.20%-18.64%+149.35%CTSOCytosorbents0.00%-3.00%-7.62%+3.57%+4.91%MODDModular Medical0.00%-20.00%+9.15%-39.31%-51.65%STRRStar Equity0.00%-13.06%-0.45%-3.95%-52.91%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHFSNuwellisN/AN/AN/AN/AN/AN/AN/AN/ACTSOCytosorbents2.0961 of 5 stars3.53.00.00.03.10.00.6MODDModular Medical0.6322 of 5 stars0.04.00.00.00.03.30.0STRRStar Equity0.7016 of 5 stars0.03.00.00.00.61.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHFSNuwellis 0.00N/AN/AN/ACTSOCytosorbents 3.00Buy$4.67381.10% UpsideMODDModular Medical 0.00N/AN/AN/ASTRRStar Equity 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest STRR, CHFS, CTSO, and MODD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/3/2025CTSOCytosorbentsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.004/1/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.002/25/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.001/13/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00(Data available from 4/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHFSNuwellis$5.51M0.00N/AN/A$12.79 per share0.00CTSOCytosorbents$35.59M1.70N/AN/A$0.52 per share1.87MODDModular MedicalN/AN/AN/AN/A$0.25 per shareN/ASTRRStar Equity$53.36M0.13$0.36 per share6.11$14.63 per share0.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHFSNuwellis-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/ACTSOCytosorbents-$28.51M-$0.38N/AN/AN/A-49.47%-118.54%-42.31%5/8/2025 (Estimated)MODDModular Medical-$17.47M-$0.53N/A∞N/AN/A-197.97%-162.31%6/19/2025 (Estimated)STRRStar Equity$25.13M-$3.91N/AN/AN/A-12.41%-8.72%-4.62%5/19/2025 (Estimated)Latest STRR, CHFS, CTSO, and MODD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/31/2025Q4 2024CTSOCytosorbents-$0.07-$0.03+$0.04-$0.14$10.09 million$9.20 million3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million2/13/2025Q3 2025MODDModular Medical-$0.12-$0.13-$0.01-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHFSNuwellisN/AN/AN/AN/AN/ACTSOCytosorbentsN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHFSNuwellisN/A6.875.97CTSOCytosorbents1.061.971.58MODDModular MedicalN/A5.305.30STRRStar Equity0.212.051.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHFSNuwellis65.06%CTSOCytosorbents32.87%MODDModular Medical27.47%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipCHFSNuwellis0.60%CTSOCytosorbents6.60%MODDModular Medical20.46%STRRStar Equity33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHFSNuwellis666.04 millionN/ANot OptionableCTSOCytosorbents22062.50 million51.07 millionOptionableMODDModular Medical2040.67 million32.35 millionNot OptionableSTRRStar Equity4603.22 million2.14 millionNot OptionableSTRR, CHFS, CTSO, and MODD HeadlinesRecent News About These CompaniesStar Equity Q4 EPS Reduced by Litchfield Hills ResearchMarch 28, 2025 | americanbankingnews.comLitchfield Hills Research Estimates Star Equity Q1 EarningsMarch 28, 2025 | americanbankingnews.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Procaps Group (OtherPROCF) and Star Equity Holdings (STRR)March 26, 2025 | markets.businessinsider.comStar Equity Holdings, Inc. (NASDAQ:STRR) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comStar Equity Holdings Reports Mixed Q4 Earnings ResultsMarch 21, 2025 | tipranks.comStar Equity reports Q4 EPS 15c vs (10c) last yearMarch 21, 2025 | markets.businessinsider.comStar Equity Holdings, Inc. (STRR) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comStar Equity (STRR) Q4 Earnings and Revenues Top EstimatesMarch 20, 2025 | zacks.comStar Equity Holdings, Inc. Announces 2024 Fourth Quarter and Full Year Financial ResultsMarch 20, 2025 | gurufocus.comStar Equity Holdings, Inc. Announces 2024 Fourth Quarter and Full Year Financial ResultsMarch 20, 2025 | globenewswire.comStar Equity Holdings, Inc. to Announce Fourth Quarter 2024 Financial Results on March 20, 2025March 13, 2025 | quiverquant.comStar Equity Holdings to Release Fourth Quarter 2024 Financial Results on March 20thMarch 13, 2025 | globenewswire.comStar Equity Holdings announces executive bonuses and targetsMarch 13, 2025 | uk.investing.comKey deals this week: Walgreens Boots, Honeywell, Amex and moreMarch 8, 2025 | msn.comStar Equity Holdings Acquires Alliance Drilling ToolsMarch 4, 2025 | tipranks.comStar Equity Holdings, Inc.: Star Equity Holdings Acquires Alliance Drilling ToolsMarch 4, 2025 | finanznachrichten.deStar Equity’s KBS Builders wins two large commercial contractsMarch 4, 2025 | markets.businessinsider.comStar Equity acquires Alliance Drilling ToolsMarch 4, 2025 | markets.businessinsider.comKBS Builders Wins Two Large Commercial Contracts Totaling $5.2 Million for Multifamily Construction Projects in MaineMarch 4, 2025 | globenewswire.comStar Equity Holdings Acquires Alliance Drilling ToolsMarch 4, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSTRR, CHFS, CTSO, and MODD Company DescriptionsNuwellis NASDAQ:CHFSNuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.Cytosorbents NASDAQ:CTSO$0.97 -0.02 (-2.02%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$0.97 +0.00 (+0.21%) As of 04/4/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.Modular Medical NASDAQ:MODD$0.88 -0.09 (-9.57%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$0.90 +0.02 (+2.50%) As of 04/4/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.Star Equity NASDAQ:STRR$2.17 -0.10 (-4.41%) As of 04/4/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Conagra Stock Could Thrive as Tariffs Hit Other Sectors Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Advance Auto Parts Stock: A Classic Rebound Play in the Making Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
